ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow Quality Index
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Quality Index of 9.34x as of March 2026. Operating cash flow of $33.98 Million exceeds net income of $3.64 Million, indicating high earnings quality where cash backs reported profits. Explore ACAD cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ACADIA Pharmaceuticals Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for ACADIA Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of ACADIA Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ACADIA Pharmaceuticals Inc (2010–2025)
Year-by-year earnings quality comparison for ACADIA Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is ACADIA Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | $109.84 Million | $391.00 Million | ▼ -59.7% |
| 2024 | 0.70x | $157.72 Million | $226.45 Million | ▲ +198.5% |
| 2010 | -0.71x | $-10.70 Million | $15.14 Million | — |